A molecular view of cisplatin's mode of action: interplay with DNA bases and acquired resistance

Bibliographic Details
Main Author: Marques, M. P. M.
Publication Date: 2015
Other Authors: Gianolio, Diego, Cibin, Giannantonio, Tomkinson, John, Parker, Stewart F., Valero, Rosendo, Pedro Lopes, R, Carvalho, Luís A. E. Batista de
Format: Article
Language: eng
Source: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Download full: http://hdl.handle.net/10316/33721
https://doi.org/10.1039/c4cp05183a
Summary: The interaction of the widely used anticancer drug cisplatin with DNA bases was studied by EXAFS and vibrational spectroscopy (FTIR, Raman and INS), coupled with DFT/plane-wave calculations. Detailed information was obtained on the local atomic structure around the Pt(ii) centre, both in the cisplatin-purine (adenine and guanine) and cisplatin-glutathione adducts. Simultaneous neutron and Raman scattering experiments allowed us to obtain a reliable and definite picture of this cisplatin interplay with its main pharmacological target (DNA), at the molecular level. The vibrational experimental spectra were fully assigned in the light of the calculated pattern for the most favoured geometry of each drug-purine adduct, and cisplatin's preference for guanine (G) relative to adenine (A) within the DNA double helix was experimentally verified: a complete N by S substitution in the metal coordination sphere was only observed for [cDDP-A2], reflecting a somewhat weaker Pt-A binding relative to Pt-G. The role of glutathione on the drug's pharmacokinetics, as well as on the stability of platinated DNA adducts, was evaluated as this is the basis for glutathione-mediated intracellular drug scavenging and in vivo resistance to Pt-based anticancer drugs. Spectroscopic evidence of the metal's preference for glutathione's sulfur over purine's nitrogen binding sites was gathered, at least two sulfur atoms being detected in platinum's first coordination sphere.
id RCAP_deb1d7a1f7703a4f989ca850d2592cab
oai_identifier_str oai:estudogeral.uc.pt:10316/33721
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling A molecular view of cisplatin's mode of action: interplay with DNA bases and acquired resistanceAdenineAntineoplastic AgentsCisplatinDNA AdductsGlutathioneGuanineModels, MolecularNucleic Acid ConformationSpectroscopy, Fourier Transform InfraredSpectrum Analysis, RamanX-Ray Absorption SpectroscopyThe interaction of the widely used anticancer drug cisplatin with DNA bases was studied by EXAFS and vibrational spectroscopy (FTIR, Raman and INS), coupled with DFT/plane-wave calculations. Detailed information was obtained on the local atomic structure around the Pt(ii) centre, both in the cisplatin-purine (adenine and guanine) and cisplatin-glutathione adducts. Simultaneous neutron and Raman scattering experiments allowed us to obtain a reliable and definite picture of this cisplatin interplay with its main pharmacological target (DNA), at the molecular level. The vibrational experimental spectra were fully assigned in the light of the calculated pattern for the most favoured geometry of each drug-purine adduct, and cisplatin's preference for guanine (G) relative to adenine (A) within the DNA double helix was experimentally verified: a complete N by S substitution in the metal coordination sphere was only observed for [cDDP-A2], reflecting a somewhat weaker Pt-A binding relative to Pt-G. The role of glutathione on the drug's pharmacokinetics, as well as on the stability of platinated DNA adducts, was evaluated as this is the basis for glutathione-mediated intracellular drug scavenging and in vivo resistance to Pt-based anticancer drugs. Spectroscopic evidence of the metal's preference for glutathione's sulfur over purine's nitrogen binding sites was gathered, at least two sulfur atoms being detected in platinum's first coordination sphere.2015-02-21info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/33721http://hdl.handle.net/10316/33721https://doi.org/10.1039/c4cp05183aengMarques, M. P. M.Gianolio, DiegoCibin, GiannantonioTomkinson, JohnParker, Stewart F.Valero, RosendoPedro Lopes, RCarvalho, Luís A. E. Batista deinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2021-10-08T07:58:49Zoai:estudogeral.uc.pt:10316/33721Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:55:25.514066Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv A molecular view of cisplatin's mode of action: interplay with DNA bases and acquired resistance
title A molecular view of cisplatin's mode of action: interplay with DNA bases and acquired resistance
spellingShingle A molecular view of cisplatin's mode of action: interplay with DNA bases and acquired resistance
Marques, M. P. M.
Adenine
Antineoplastic Agents
Cisplatin
DNA Adducts
Glutathione
Guanine
Models, Molecular
Nucleic Acid Conformation
Spectroscopy, Fourier Transform Infrared
Spectrum Analysis, Raman
X-Ray Absorption Spectroscopy
title_short A molecular view of cisplatin's mode of action: interplay with DNA bases and acquired resistance
title_full A molecular view of cisplatin's mode of action: interplay with DNA bases and acquired resistance
title_fullStr A molecular view of cisplatin's mode of action: interplay with DNA bases and acquired resistance
title_full_unstemmed A molecular view of cisplatin's mode of action: interplay with DNA bases and acquired resistance
title_sort A molecular view of cisplatin's mode of action: interplay with DNA bases and acquired resistance
author Marques, M. P. M.
author_facet Marques, M. P. M.
Gianolio, Diego
Cibin, Giannantonio
Tomkinson, John
Parker, Stewart F.
Valero, Rosendo
Pedro Lopes, R
Carvalho, Luís A. E. Batista de
author_role author
author2 Gianolio, Diego
Cibin, Giannantonio
Tomkinson, John
Parker, Stewart F.
Valero, Rosendo
Pedro Lopes, R
Carvalho, Luís A. E. Batista de
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Marques, M. P. M.
Gianolio, Diego
Cibin, Giannantonio
Tomkinson, John
Parker, Stewart F.
Valero, Rosendo
Pedro Lopes, R
Carvalho, Luís A. E. Batista de
dc.subject.por.fl_str_mv Adenine
Antineoplastic Agents
Cisplatin
DNA Adducts
Glutathione
Guanine
Models, Molecular
Nucleic Acid Conformation
Spectroscopy, Fourier Transform Infrared
Spectrum Analysis, Raman
X-Ray Absorption Spectroscopy
topic Adenine
Antineoplastic Agents
Cisplatin
DNA Adducts
Glutathione
Guanine
Models, Molecular
Nucleic Acid Conformation
Spectroscopy, Fourier Transform Infrared
Spectrum Analysis, Raman
X-Ray Absorption Spectroscopy
description The interaction of the widely used anticancer drug cisplatin with DNA bases was studied by EXAFS and vibrational spectroscopy (FTIR, Raman and INS), coupled with DFT/plane-wave calculations. Detailed information was obtained on the local atomic structure around the Pt(ii) centre, both in the cisplatin-purine (adenine and guanine) and cisplatin-glutathione adducts. Simultaneous neutron and Raman scattering experiments allowed us to obtain a reliable and definite picture of this cisplatin interplay with its main pharmacological target (DNA), at the molecular level. The vibrational experimental spectra were fully assigned in the light of the calculated pattern for the most favoured geometry of each drug-purine adduct, and cisplatin's preference for guanine (G) relative to adenine (A) within the DNA double helix was experimentally verified: a complete N by S substitution in the metal coordination sphere was only observed for [cDDP-A2], reflecting a somewhat weaker Pt-A binding relative to Pt-G. The role of glutathione on the drug's pharmacokinetics, as well as on the stability of platinated DNA adducts, was evaluated as this is the basis for glutathione-mediated intracellular drug scavenging and in vivo resistance to Pt-based anticancer drugs. Spectroscopic evidence of the metal's preference for glutathione's sulfur over purine's nitrogen binding sites was gathered, at least two sulfur atoms being detected in platinum's first coordination sphere.
publishDate 2015
dc.date.none.fl_str_mv 2015-02-21
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10316/33721
http://hdl.handle.net/10316/33721
https://doi.org/10.1039/c4cp05183a
url http://hdl.handle.net/10316/33721
https://doi.org/10.1039/c4cp05183a
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133841623875584